MR

Munich Reinsurance Portfolio holdings

AUM $4.11B
This Fund
S&P 500
This Quarter Est. Return
1 Year Est. Return
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$4.11B
AUM Growth
+$125M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
228
New
Increased
Reduced
Closed

Top Buys

1 +$68.9M
2 +$66.4M
3 +$49.2M
4
ATO icon
Atmos Energy
ATO
+$43.6M
5
MRSH
Marsh
MRSH
+$43.1M

Top Sells

1 +$58.1M
2 +$55.7M
3 +$54.5M
4
RF icon
Regions Financial
RF
+$52.5M
5
PFE icon
Pfizer
PFE
+$40.4M

Sector Composition

1 Technology 26.04%
2 Financials 16.02%
3 Healthcare 13.36%
4 Communication Services 10.62%
5 Industrials 8.56%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SNPS icon
101
Synopsys
SNPS
$85.9B
$5.01M 0.12%
10,560
-48,182
ZBH icon
102
Zimmer Biomet
ZBH
$19.8B
$4.92M 0.12%
54,166
+53,053
EW icon
103
Edwards Lifesciences
EW
$48.4B
$4.65M 0.11%
53,923
+52,494
MRVL icon
104
Marvell Technology
MRVL
$68.6B
$4.4M 0.11%
+50,722
TFC icon
105
Truist Financial
TFC
$63.8B
$4.36M 0.11%
+87,944
FN icon
106
Fabrinet
FN
$22.1B
$4.34M 0.11%
9,396
+1,380
TRI icon
107
Thomson Reuters
TRI
$44.2B
$4.29M 0.1%
+32,282
WAT icon
108
Waters Corp
WAT
$31.3B
$4.28M 0.1%
11,157
+4,006
JNJ icon
109
Johnson & Johnson
JNJ
$591B
$4.25M 0.1%
20,553
+2,731
NTAP icon
110
NetApp
NTAP
$20.2B
$4.11M 0.1%
37,921
-55,885
WDAY icon
111
Workday
WDAY
$35B
$4.04M 0.1%
+18,617
PGR icon
112
Progressive
PGR
$120B
$3.99M 0.1%
17,344
-979
CI icon
113
Cigna
CI
$74.9B
$3.98M 0.1%
14,392
-8,254
DOV icon
114
Dover
DOV
$30.6B
$3.98M 0.1%
20,102
+18,780
TRV icon
115
Travelers Companies
TRV
$65.9B
$3.91M 0.1%
13,375
+12,869
ACGL icon
116
Arch Capital
ACGL
$35.7B
$3.83M 0.09%
+39,609
CFG icon
117
Citizens Financial Group
CFG
$26.8B
$3.77M 0.09%
64,009
+24,236
KGC icon
118
Kinross Gold
KGC
$43.5B
$3.7M 0.09%
129,246
+123,796
CMCSA icon
119
Comcast
CMCSA
$111B
$3.65M 0.09%
121,918
-50,127
HAL icon
120
Halliburton
HAL
$29.5B
$3.6M 0.09%
+126,344
CDNS icon
121
Cadence Design Systems
CDNS
$82.2B
$3.59M 0.09%
11,379
+10,914
NBIX icon
122
Neurocrine Biosciences
NBIX
$13.2B
$3.5M 0.09%
24,821
+10,168
IQV icon
123
IQVIA
IQV
$27.5B
$3.44M 0.08%
+15,124
BMY icon
124
Bristol-Myers Squibb
BMY
$125B
$3.35M 0.08%
61,721
STT icon
125
State Street
STT
$36.7B
$3.32M 0.08%
+25,465